Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PSA | Common Stock | Options Exercise | $823K | +5.16K | +0.04% | $159.40 | 14.1M | Dec 22, 2022 | Direct | |
transaction | PSA | Common Stock | Options Exercise | $881K | +5.16K | +0.04% | $170.60 | 14.1M | Dec 22, 2022 | Direct | |
transaction | PSA | Common Stock | Options Exercise | $939K | +5.16K | +0.04% | $181.95 | 14.1M | Dec 22, 2022 | Direct | |
transaction | PSA | Common Stock | Options Exercise | $1.29M | +5.16K | +0.04% | $250.29 | 14.1M | Dec 22, 2022 | Direct | |
transaction | PSA | Common Stock | Options Exercise | $1.12M | +5.16K | +0.04% | $216.83 | 14.1M | Dec 22, 2022 | Direct | |
transaction | PSA | Common Stock | Options Exercise | $968K | +5.16K | +0.04% | $187.57 | 14.1M | Dec 22, 2022 | Direct | |
transaction | PSA | Common Stock | Options Exercise | $1.09M | +5.16K | +0.04% | $211.30 | 14.2M | Dec 22, 2022 | Direct | |
holding | PSA | Common Stock | 11.3K | Dec 22, 2022 | Direct | F1 | |||||
holding | PSA | Common Stock | 5.5K | Dec 22, 2022 | Direct | F2 | |||||
holding | PSA | Common Stock | 2.79M | Dec 22, 2022 | By Trust | ||||||
holding | PSA | Common Stock | 27.3K | Dec 22, 2022 | By IRA | F3 | |||||
holding | PSA | Common Stock | 1.3K | Dec 22, 2022 | By Husband | ||||||
holding | PSA | Common Stock | 295K | Dec 22, 2022 | By LLC | F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PSA | Stock Option (Right to Buy) | Options Exercise | $0 | -5.16K | -100% | $0.00* | 0 | Dec 22, 2022 | Common Stock | 5.16K | $159.40 | Direct | F5, F6 |
transaction | PSA | Stock Option (Right to Buy) | Options Exercise | $0 | -5.16K | -100% | $0.00* | 0 | Dec 22, 2022 | Common Stock | 5.16K | $170.60 | Direct | F5, F7 |
transaction | PSA | Stock Option (Right to Buy) | Options Exercise | $0 | -5.16K | -100% | $0.00* | 0 | Dec 22, 2022 | Common Stock | 5.16K | $181.95 | Direct | F5, F8 |
transaction | PSA | Stock Option (Right to Buy) | Options Exercise | $0 | -5.16K | -100% | $0.00* | 0 | Dec 22, 2022 | Common Stock | 5.16K | $250.29 | Direct | F5, F9 |
transaction | PSA | Stock Option (Right to Buy) | Options Exercise | $0 | -5.16K | -100% | $0.00* | 0 | Dec 22, 2022 | Common Stock | 5.16K | $216.83 | Direct | F10, F11 |
transaction | PSA | Stock Option (Right to Buy) | Options Exercise | $0 | -5.16K | -100% | $0.00* | 0 | Dec 22, 2022 | Common Stock | 5.16K | $187.57 | Direct | F10, F12 |
transaction | PSA | Stock Option (Right to Buy) | Options Exercise | $0 | -5.16K | -100% | $0.00* | 0 | Dec 22, 2022 | Common Stock | 5.16K | $211.30 | Direct | F10, F13 |
Id | Content |
---|---|
F1 | By Tamara Hughes Gustavson and B. Wayne Hughes, Jr. - Separate Property. |
F2 | By reporting person and husband. |
F3 | By custodian of an IRA for benefit of reporting person. |
F4 | By LLC of which reporting person is a member and manager. |
F5 | Stock option granted pursuant to the 2007 Equity and Performance-Based Incentive Compensation Plan. Option vests in three (3) equal annual installments beginning one (1) year from grant date. |
F6 | This option was previously reported as an option for 5,000 shares of common stock at an exercise price of $164.62, but, pursuant to anti-dilution provisions of PSA's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by PSA on July 22, 2022. |
F7 | This option was previously reported as an option for 5,000 shares of common stock at an exercise price of $176.19, but, pursuant to anti-dilution provisions of PSA's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by PSA on July 22, 2022. |
F8 | This option was previously reported as an option for 5,000 shares of common stock at an exercise price of $187.91, but, pursuant to anti-dilution provisions of PSA's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by PSA on July 22, 2022. |
F9 | This option was previously reported as an option for 5,000 shares of common stock at an exercise price of $258.49, but, pursuant to anti-dilution provisions of PSA's 2007 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by PSA on July 22, 2022. |
F10 | Stock option granted pursuant to the 2016 Equity and Performance-Based Incentive Compensation Plan. Option vests in three (3) equal annual installments beginning one (1) year from grant date. |
F11 | This option was previously reported as an option for 5,000 shares of common stock at an exercise price of $223.93, but, pursuant to anti-dilution provisions of PSA's 2016 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by PSA on July 22, 2022. |
F12 | This option was previously reported as an option for 5,000 shares of common stock at an exercise price of $193.71, but, pursuant to anti-dilution provisions of PSA's 2016 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by PSA on July 22, 2022. |
F13 | This option was previously reported as an option for 5,000 shares of common stock at an exercise price of $218.22, but, pursuant to anti-dilution provisions of PSA's 2016 Equity and Performance-Based Incentive Compensation Plan, was adjusted to reflect the special dividend declared by PSA on July 22, 2022. |